Reducing chemoresistance by targeting signaling pathways highlights its therapeutic potential [11].Although the expression of GAS5 has been investigated in a number of human cancers, such as breast cancer and lung cancer, its pan-cancer expression pattern is not well-characterized. The gene discussed is GAS5; the disease is breast cancer.